CLS 003 - Comera Life Sciences
Alternative Names: CLS-003 - ComeraLatest Information Update: 05 Apr 2023
At a glance
- Originator Comera Life Sciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 03 Apr 2023 Comera Life Sciences has patent protection covering expansion of claims and exclusive rights pertaining to certain excipients in its proprietary SQore™ platform, in South Korea
- 03 Apr 2023 Comera Life Sciences receives Notices of Allowance covering expansion of claims and exclusive rights pertaining to certain excipients in its proprietary SQore™ platform, in USA and Japan
- 20 Jan 2023 Early research in Unspecified in USA (SC) (Comera Pipeline, January 2023)